Medtronic said the separation of its businesses isn’t expected to affect the company’s dividend policy.
Medtronic PLC said it is separating its patient-monitoring and respiratory intervention businesses in an effort to boost its long-term prospects.
The businesses, which include pulse oximeters and ventilators, generate about $2.2 billion in annual sales, or nearly 7% of Medtronic’s overall revenue.
Medtronic said the businesses, with over 8,000 employees globally, were slightly below the company’s overall performance in terms of gross margin and revenue growth.